Neurological Symptoms as (Post) Pandemic Burden in Children and Adolescents-Single Tertiary Center Experience from Croatia
Iranian Journal of Child Neurology,
Vol. 20 No. 1 (2026),
1 Dey 2026
,
Page 63-69
https://doi.org/10.22037/ijcn.v20i1.47769
Abstract
Objectives:
Although COVID-19 primarily affects the respiratory system, the central and peripheral nervous system may be involved. Neurological manifestations of COVID-19 infection occur in acute or post-acute stages and may persist as long-lasting symptoms known as “long-COVID“ or “post-COVID-19”. This study aimed to investigate the clinical profile, outcomes, and management of neurological manifestations after COVID-19 infection in children.
Materials & Methods:
A retrospective chart review was conducted of all pediatric patients admitted to our tertiary pediatric center with neurological symptoms following COVID-19, meeting criteria for long COVID-19/post-COVID-19, from December 2020 through the end of 2021, with a one-year follow-up period.
Results:
Eighty-four patients were included (median age 12.7 years; range, 0.5-18 years). Girls were more affected than the boys (female n = 51; 60.7%, χ2 = 3, 86; p = 0,049). The most common neurological manifestation were headache (n = 47; 55.95%), dizziness (n = 19; 22.6%), visual disturbances (n = 9; 10.7%), afebrile seizures (n = 6; 7.1%), and anosmia/hyposmia (n = 4; 4.7%). Overall, 19 (22.6%) patients required psychological support, of whom 4 (4.8%) patients required psychiatric consultation due to suspected mental disorder. The most significant number of patients with neurological symptoms after COVID-19 was observed between October 2020 and March 2021 (n=44, 52.4%).
Conclusion:
The obtained findings align with the results from similar studies and show that neurological manifestations after COVID-19 infection appear more frequently in school-aged children, predominantly in female patients. Neurological post-COVID-19 symptoms require medical attention to exclude more severe conditions.
- long COVID
- post COVID
- children
- neurological symptoms
How to Cite
References
Gupta M, Gupta N, Esang M. Long COVID in Children and Adolescents. Prim Care Companion CNS Disord 2022;24(2):21r03218.
Laçinel Gürlevik S, Günbey C, Ozsurekci Y, Oygar PD, Kesici S, Gocmen R, et al. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review. Eur J Paediatr Neurol 2022;37:139–54.
Tavčar P, Potokar M, Kolenc M, Korva M, Avšič-Županc T, Zorec R et al. Neurotropic Viruses, Astrocytes, and COVID-19. Front Cell Neurosci 2021;15:662578.
Desforges M, Le Coupanec A, Brison E, Meessen-Pinard M, Talbot PJ. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 2014;807:75-96.
Stephenson T, Allin B, Nugawela MD, Rojas N, Dalrymple E, Pereira SP et al. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child 2022;107(7):674-80.
WHO. A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus, 16 February 2023 [Internet]. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1. Accessed September 14, 2024.
Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2021;22(4):e102-7.
Izquierdo-Pujol J, Moron-Lopez S, Dalmau J, Gonzalez-Aumatell A, Carreras-Abad C, Mendez M, et al. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front Pediatr 2022;10:894204.
Morello R, Mariani F, Mastrantoni L, De Rose C, Zampino G, Munblit D, et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. EClinicalMedicine 2023;59:101961.
Kumar P, Kana Ram Jat. Post-COVID-19 Sequelae in Children. Indian J Pediatr 2023;90(6):605–11.
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61(4):344–9.
National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE [Internet]. Available at: https://www.nice.org.uk/guidance/ng188. Accessed September 19, 2024.
Burki T. Clinical case definition of post-COVID-19 condition in children: a good start, but improvements are needed. Lancet Respir Med 2023;11(4):314.
Bauer L, Laksono BM, de Vrij FMS, Kushner SA, Harschnitz O, van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends in Neurosci 2022;45(5):358–68.
Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel) 2021;9(5):497.
Principi N, Esposito S. Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated? Ital J Pediatr 2021;47(1):191.
Atchison CJ, Whitaker M, Donnelly CA, Chadeau-Hyam M, Riley S, Darzi A, et al. Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: a large community cross-sectional study in England. Arch Dis Child 2023;108(7):e12.
Taslem Mourosi J, Anwar S, Hosen MJ. The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors. Infect Genet Evol 2022;103:105338.
Funk AL, Kuppermann N, Florin TA, Tancredi DJ, Xie J, Kim K et al. Post–COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection. JAMA Netw Open 2022;5(7):e2223253.
Haddad A, Janda A, Renk H, Stich M, Frieh P, Kaier K et al. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. EBioMedicine 2022;84:104245.
Pinto M, Mensah A, Nugawela MD, Stephenson T, Ladhani S, Dalrymple E, et al. Long COVID in Children and Youth After Infection or Reinfection with the Omicron Variant: A Prospective Observational Study. J Pediatr 2023;259:113463.
Ferenčak I, Obrovac M, Žmak L, Kuzle J, Petrović G, Vilibić-Čavlek T, et al. SARS-CoV-2 Omicron Variant in Croatia—Rapid Detection of the First Case and Cross-Border Spread. Pathogens 2022;11(5):511.
Ravens-Sieberer U, Erhart M, Devine J, Gilbert M, Reiss F, Barkmann C, et al. Child and Adolescent Mental Health During the COVID-19 Pandemic: Results of the Three-Wave Longitudinal COPSY Study. J Adolesc Health 2022;71(5):570-8.
Kikkenborg Berg S, Palm P, Nygaard U, Bundgaard H, Petersen MNS, Rosenkilde S et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0–14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health 2022;6(9):614-23.
Guido CA, Lucidi F, Midulla F, Zicari AM, Bove E, Avenoso F et al. Neurological and psychological effects of long COVID in a young population: A cross-sectional study. Front Neurol 2022;13:925144.
Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open 2021; 4(10):e2128568.
Goldman RD. Long COVID in children. Can Fam Physician 2022;68(4):263–5.
Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health 2022;6(5):294-302.
Leng X, Hu G, Wang X, Zhang Y, Guo Y, Song C et al. Risk of COVID‐19 infection and seizure exacerbation among patients with epilepsy during the peak of Omicron wave. Epilepsia Open 2024;9(4):1416–25.
Taquet M, Devinsky O, Cross JH, Harrison PJ, Sen A. Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study. Neurology 2023;100(8):e790-e799.
- Abstract Viewed: 45 times